Blog
RSS FeedPosted by Michael Wonder on 12 Sep 2023
Taking a proportionate approach to technology appraisals
12 September 2023 - In 2022, NICE introduced the first phase of a new proportionate approach to technology appraisals. ...
Posted by Michael Wonder on 07 Jun 2022
Global expert panel publishes guidance on deliberative processes for health technology assessment
7 June 2022 - Value in Health announced today the publication of guidance regarding the establishment or improvement of deliberative ...
Posted by Michael Wonder on 19 Aug 2021
NICE’s health technology assessment methods and processes to be evaluated
19 August 2021 - NICE has launched a public consultation on proposed changes to the way it develops recommendations across ...
Posted by Michael Wonder on 30 Mar 2021
NICE methods and process review aims to create fertile ground for innovation
29 March 2021 - The way NICE reviews new medicines is about to go through its biggest change in years – ...
Posted by Michael Wonder on 04 Jan 2021
NICE collaboration on streamlined licensing and patient access process for new medicines opened on January 1st
4 January 2020 - Companies can now submit medicines for the new Innovative Licensing and Access Pathway following close collaboration between ...
Posted by Michael Wonder on 12 Oct 2020
NICE proposes simplifying how medicines and medical devices are selected for evaluation
12 October 2020 - As part of the work underway to review the methods and processes NICE uses to develop guidance ...
Posted by Michael Wonder on 20 Jan 2020
After 20 years of using economic evaluation, should NICE be considered a methods innovator?
13 January 2020 - NICE is only one of several organisations internationally that uses economic evaluation as part of decision ...
Posted by Michael Wonder on 22 Jul 2019
NICE announces details of health technology evaluation methods review
22 July 2019 - Following approval at its recent Board meeting NICE has confirmed the details of its review of the ...
Posted by Michael Wonder on 07 Nov 2018
NHS England in legal battle with American firm over medicine procurement
7 November 2018 - An American pharmaceutical company has launched a legal challenge against NHS England over a procurement process ...
Posted by Michael Wonder on 23 Jan 2018
Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries
23 January 2018 - Although health technology assessment systems base their decision making process either on economic evaluations or comparative clinical ...
Posted by Michael Wonder on 09 Aug 2017
Comprehensive assessment of complex technologies: integrating various aspects in health technology assessment
7 August 2017 - Despite recent development of health technology assessment (HTA) methods, there are still methodological gaps for the assessment ...
Posted by Michael Wonder on 24 Jul 2017
Managing conflicts of interest – making good decisions
24 July 2017 - NICE is seeking views on a new conflicts of interest policy to ensure its committees’ decisions ...
Posted by Michael Wonder on 15 May 2017
HTA programme response to the challenges of dealing with orphan medicinal products: process evaluation in selected European countries
15 May 2017 - Challenges commonly encountered in HTA of orphan medicinal products (OMPs) were identified in Advance-HTA. Since then, new ...
Posted by Michael Wonder on 06 Feb 2017
Medicines evaluation not keeping pace with scientific progress, says ABPI
3 February 2017 - Following the news that a new breast cancer medicine - palbociclib - from Pfizer has been ...
Posted by Michael Wonder on 22 Oct 2016
Deal or delay: NICE's new negotiating chip
20 October 2016 - With the UK's NHS facing a financial challenge that shows no signs of abating any time ...